Oestrogenic and antiandrogenic chemicals in the environment: effects on male reproductive health

References

• Sharpe R M, Skakkebaek N E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?. Lancet 1993; 341: 1392
   PubMed Web of Science ®Google Scholar
• Colborn T, vom Saal F S, Soto A M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101: 378–84
   PubMed Web of Science ®Google Scholar
• Toppari J, Larsen J C, Christiansen P, Giwercman A, Grandjean P, Guillette L J, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996; 104(Suppl 4)741–803
   PubMed Web of Science ®Google Scholar
• Kelce W R, Gray L E, Wilson E M. Antiandrogens as environmental endocrine disruptors. Reprod Fertil Dev 1998; 10: 105–11
   PubMed Web of Science ®Google Scholar
• Jobling S, Reynolds T, White R, Parker M G, Sumpter J P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 1995; 103: 582–7
   PubMed Web of Science ®Google Scholar
• Couse J F, Korach K S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999; 20: 358–417
   PubMed Web of Science ®Google Scholar
• Iafrati M D, Karas R H, Aronovitz M, Kim S, Sullivan T R, Lubahn D B, et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nut Med 1997; 3: 545–8
   PubMed Web of Science ®Google Scholar
• Smith E P, Boyd J, Frank G R, Takahashi H, Cohen R M, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056–61
   PubMed Web of Science ®Google Scholar
• Eddy E M, Washburn T F, Bunch D O, Goulding E H, Gladen B C, Lubahn D B, et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 1996; 137: 4796–805
   PubMed Web of Science ®Google Scholar
• Shupnik M A. Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone. Biol Reprod 1996; 54: 279–86
   PubMed Web of Science ®Google Scholar
• Bulger W H, Muccitelli R M, Kupfer D. Interactions of methoxychlor, methoxychlor base-soluble contaminant, and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane with rat uterine estrogen receptor. J Toxicol Environ Health 1978; 4: 881–93
   PubMed Web of Science ®Google Scholar
• White R, Jobling S, Hoare S A, Sumpter J P, Parker M G. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994; 135: 175–82
   PubMed Web of Science ®Google Scholar
• Safe S H. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 1994; 24: 87–149
   PubMed Web of Science ®Google Scholar
• Kurzer M S, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17: 353–81
   PubMed Web of Science ®Google Scholar
• Kelce W R, Monosson E, Gamcsik M P, Laws S C, Gray L E. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 1994; 126: 276–85
   PubMed Web of Science ®Google Scholar
• Gray L E, Ostby J, Monosson E, Kelce W R. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health 1999; 15: 48–64
   PubMed Web of Science ®Google Scholar
• Mylchreest E, Sar M, Cattley R C, Foster P M. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol 1999; 156: 81–95
   PubMed Web of Science ®Google Scholar
• Mylchreest E, Wallace D G, Cattley R C, Foster P M. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation. Toxicol Sci 2000; 55: 143–51
   PubMed Web of Science ®Google Scholar
• Parks L G, Ostby J S, Lambright C R, Abbott B D, Klinefelter G R, Barlow N J, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 2000; 58: 33949
   Web of Science ®Google Scholar
• Tas J W, Keizer A, Opperhuizen A. Bioaccumulation and lethal body burden of four triorganotin compounds. Bull Environ Contam Toxicol 1996; 57: 146–54
   PubMed Web of Science ®Google Scholar
• Bannwart C, Adlercreutz H, Wahala K, Kotiaho T, Hesso A, Brunow G, et al. Identification of the phyto-oestrogen 3′,7-dihydroxyisoflavan, an isomer of equol, in human urine and cow's milk. Biomed Environ Mass Spectrom 1988; 17: 1–6
   PubMedGoogle Scholar
• Simonich S L, Hites R A. Global distribution of persistent organochlorine compounds. Science 1995; 269: 18514
   Web of Science ®Google Scholar
• Gustafsson J A. Estrogen receptor-beta - a new dimension in estrogen mechanism of action. J Endocrinol 1999; 163: 379–83
   PubMed Web of Science ®Google Scholar
• Saunders P T, Fisher J S, Sharpe R M, Millar M R. Expression of oestrogen receptor beta (ER beta) occurs in multiple cell types, including some germ cells, in the rat testis. J Endocrinol 1998; 156: R13–7
   PubMed Web of Science ®Google Scholar
• Kuiper G G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863–70
   PubMed Web of Science ®Google Scholar
• Shughrue P J, Lane M V, Scrimo P J, Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998; 63: 498–504
   PubMed Web of Science ®Google Scholar
• Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82: 4258–65
   PubMed Web of Science ®Google Scholar
• Fisher J S, Millar M R, Majdic G, Saunders P T, Fraser H M, Sharpe R M. Immunolocalisation of oestrogen receptor-alpha within the testis and excurrent ducts of the rat and marmoset monkey from perinatal life to adulthood. J Endocrinol 1997; 153: 485–95
   PubMed Web of Science ®Google Scholar
• Bremner W J, Millar M R, Sharpe R M, Saunders P T. Immuno-histochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology 1994; 135: 1227–34
   PubMed Web of Science ®Google Scholar
• Majdic G, Millar M R, Saunders P T. Immunolocalisation of androgen receptor to interstitial cells in fetal rat testes and to mesenchymal and epithelial cells of associated ducts. J Endocrinol 1995; 147: 285–93
   PubMed Web of Science ®Google Scholar
• Risbridger G, Wang H, Young P, Kurita T, Wong Y Z, Lubahn D, et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001; 229: 432–42
   Google Scholar
• Hayward S W, Rosen M A, Cunha G R. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol 1997; 79(Suppl 2)18–26
   PubMedGoogle Scholar
• Brandenberger A W, Tee M K, Lee J Y, Chao V, Jaffe R B. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997; 82: 3509–12
   PubMed Web of Science ®Google Scholar
• van Pelt A M, deRooij D G, van der Burg B, van der Saag P T, Gustafsson J A, Kuiper G G. Ontogeny of estrogen receptor-beta expression in rat testis. Endocrinology 1999; 140: 478–83
   PubMed Web of Science ®Google Scholar
• Friend K E, Ang L W, Shupnik M A. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 1995; 92: 4367–71
   PubMed Web of Science ®Google Scholar
• Ogawa S, Chester A E, Hewitt S C, Walker V R, Gustafsson J A, Smithies O, et al. Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta. Proc Natl Acad Sci USA 2000; 97: 14737–41
   PubMed Web of Science ®Google Scholar
• Carson-Jurica M A, Schrader W T, O'Malley B W. Steroid receptor family: structure and functions. Endocr Rev 1990; 11: 201–20
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen B S. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 1996; 54: 287–93
   PubMed Web of Science ®Google Scholar
• Brzozowski A M, Pike A C, Dauter Z, Hubbard R E, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389: 753–8
   PubMed Web of Science ®Google Scholar
• Pilat M J, Hafner M S, Kral L G, Brooks S C. Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens. Biochemistry 1993; 32: 7009–15
   PubMed Web of Science ®Google Scholar
• Pettersson K, Grandien K, Kuiper G G, Gustafsson J A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997; 11: 1486–96
   PubMed Web of Science ®Google Scholar
• Smith C L. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 1998; 58: 627–32
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper G G, Nilsson S, Gustafsson J, Kushner P J, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277: 1508–10
   PubMed Web of Science ®Google Scholar
• Van Den Bemd G J, Kuiper G G, Pols H A, Van Leeuwen J P. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Biochem Biophys Res Commun 1999; 261: 1–5
   PubMed Web of Science ®Google Scholar
• Gaido K W, Leonard L S, Maness S C, Hd J M, McDonnell D P, Saville B, et al. Differential interaction of the methoxy-chlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloro-ethane with estrogen receptors alpha and beta. Endocrinology 1999; 140: 5746–53
   PubMed Web of Science ®Google Scholar
• Watanabe T, Inoue S, Ogawa S, Ishii Y, Hiroi H, Ikeda K, et al. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between between estrogen receptors alpha and beta. Biochem Biophys Res Commun 1997; 236: 140–5
   PubMed Web of Science ®Google Scholar
• Kuiper G G, Lemmen J G, Carlsson B, Corton J C, Safe S H, van der Saag I T, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252–63
   PubMed Web of Science ®Google Scholar
• Kester M H, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany C N, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 2000; 141: 1897–900
   PubMed Web of Science ®Google Scholar
• Bradlow L, Telang N T, Osborn M P. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters. Adv Exp Med Biol 1996; 387: 285–96
   PubMedGoogle Scholar
• Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147–53
   PubMed Web of Science ®Google Scholar
• Ignar-Trowbridge D M, Nelson K G, Bidwell M C, Curtis S W, Washburn T F, McLachlan J A, et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 1992; 89: 4658–62
   PubMed Web of Science ®Google Scholar
• Le Blanc G A, Bain L J, Wilson V S. Pesticides: multiple mechanisms of demasculinization. Mol Cell Endocrinol 1997; 126: 1–5
   PubMed Web of Science ®Google Scholar
• Blok L J, Bartlett J M, Bolt-De Vries J, Themmen A P, Brinkmann A O, Weinbauer G F, et al. Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis. Int J Androl 1992; 15: 182–98
   PubMedGoogle Scholar
• Kelce W R, Stone C R, Laws S C, Gray L E, Kemppainen J A, Wilson E M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 1995; 375: 581–5
   PubMed Web of Science ®Google Scholar
• You L, Casanova M, Archibeque-Engle S, Sar M, Fan L Q, Heck H A. Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p'-DDE. Toxicol Sci 1998; 45: 162–73
   PubMed Web of Science ®Google Scholar
• Gray L E, Ostby J, Furr J, Price M, Veeramachaneni D N, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 2000; 58: 350–65
   PubMed Web of Science ®Google Scholar
• Akingbemi B T, Youker R T, Somas C M, Ge R, Katz E, Klinefelter G R, et al. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl) phthalate. Biol Reprod 2001, in press
   PubMed Web of Science ®Google Scholar
• Maness S C, McDonnel D P, Gaido K W. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepC2 human hepatoma cells. Toxicol Appl Pharmacol 1998; 151: 135–42
   PubMed Web of Science ®Google Scholar
• Sohoni P, Sumpter J P. Several environmental oestrogens are also anti-androgens. J Endocrinol 1998; 158: 327–39
   PubMed Web of Science ®Google Scholar
• Bern H A. The development of the role of hormones in development - a double remembrance. Endocrinology 1992; 13: 2037–8
   Google Scholar
• Gill W B, Schumacher G F, Bibbo M. Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES). J Reprod Med 1976; 16: 147–53
   PubMed Web of Science ®Google Scholar
• Cooper R L, Kavlock R J. Endocrine disruptors and reproductive development: a weight-of-evidence overview. J Endocrinol 1997; 152: 159–66
   PubMed Web of Science ®Google Scholar
• Preslock J P, McCann S M. Lesions of the sexually dimorphic nucleus of the preoptic area: effects upon LH, FSH and prolactin in rats. Bruin Res Bull 1987; 18: 127–34
   PubMed Web of Science ®Google Scholar
• Capel B, Lovell-Badge R. The Sry gene and sex determination in mammals. Adv Dev Biol 1993; 2: 1–35
   Google Scholar
• Ikeda Y, Swain A, Weber T J, Hentges K E, Zanaria E, Lalli E, et al. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 1996; 10: 1261–72
   PubMedGoogle Scholar
• Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. Mouse DAX-1 expression is consistent with a role in both adrenal development and sex determination. Nat Genet 1996; 12: 404–9
   PubMed Web of Science ®Google Scholar
• Majdic G, Sharpe R M, Saunders P T. Maternal oestrogen/ xenoestrogen exposure alters expression of steroidogenic factor-1 (SF-1/Ad4BP) in the fetal rat testis. Mol Cell Endocrinol 1997; 127: 91–8
   PubMed Web of Science ®Google Scholar
• Fisher J S, Turner K J, Brown D, Sharpe R M. Effect of neonatal exposure to estrogenic compounds on development of the excurrent ducts of the rat testis through puberty to adulthood. Environ Health Perspect 1999; 107: 397–405
   PubMed Web of Science ®Google Scholar
• Lee M M, Donahoe P K. Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993; 14: 152–64
   PubMed Web of Science ®Google Scholar
• Visser J A, McLuskey A, Verhoef-Post M, Kramer P, Grootegoed J A, Themmen A P. Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice. Endocrinology 1998; 139: 4244–51
   PubMed Web of Science ®Google Scholar
• Nonneman D J, Ganjam V K, Welshons W V, Vom Sad F S. Intrauterine position effects on steroid metabolism and steroid receptors of reproductive organs in male mice. Biol Reprod 1992; 47: 723–9
   PubMed Web of Science ®Google Scholar
• Ashby J, Tinwell H, Haseman J. Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 1999; 30: 156–66
   PubMed Web of Science ®Google Scholar
• Nagel S C, vom Saal F S, Thayer K A, Dhar M G, Boechler M, Welshons W V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bio-activity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 1997; 105: 70–6
   PubMed Web of Science ®Google Scholar
• vom Saal F S, Cooke P S, Buchanan D L, Palanza P, Thayer K A, Nagel S C, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998; 14: 239–60
   PubMed Web of Science ®Google Scholar
• Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 2000; 224: 61–8
   PubMed Web of Science ®Google Scholar
• Prins G S, Birch L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 1997; 138: 1801–9
   PubMed Web of Science ®Google Scholar
• Kuiper G G, Shughrue P J, Merchenthaler I, Gustafsson J A. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuro-endocrinol 1998; 19: 253–86
   PubMed Web of Science ®Google Scholar
• Gray L E, Wolf C, Lambright C, Mann P, Price M, Cooper R L, et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl-and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999; 15: 94–118
   PubMed Web of Science ®Google Scholar
• Wolf C J, LeBlanc G A, Ostby J S, Gray L E. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol Sci 2000; 55: 152–61
   PubMed Web of Science ®Google Scholar
• Abney T O, Myers R B. 17 beta-estradiol inhibition of Leydig cell regeneration in the ethane dimethylsulfonate-treated mature rat. J Androl 1991; 12: 295–304
   PubMedGoogle Scholar
• Shan L X, Hardy M P. Developmental changes in levels of luteinizing hormone receptor and androgen receptor in rat Leydig cells. Endocrinology 1992; 131: 1107–14
   PubMed Web of Science ®Google Scholar
• Magre S, Jost A. The initial phases of testicular organogenesis in the rat. An electron microscopy study. Arch Anat Microsc Morphol Exp 1980; 69: 297–318
   PubMedGoogle Scholar
• Greco T L, Payne A H. Ontogeny of expression of the genes for steroidogenic enzymes P450 side-chain cleavage, 3 beta-hydroxysteroid dehydrogenase, P450 17 alpha-hydroxylase/ C17–20 lyase, and P450 aromatase in fetal mouse gonads. Endocrinology 1994; 135: 262–8
   PubMed Web of Science ®Google Scholar
• Akingbemi B T, Ge R, Hardy M P. Leydig cells. Encyclopedia of reproduction, E Knobil, J D Neill. Academic Press, San Diego, CA 1999; 1021–33
   Google Scholar
• Nikula H, Talonpoika T, Kaleva M, Toppari J. Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols. Toxicol Appl Pharmacol 1999; 157: 166–73
   PubMed Web of Science ®Google Scholar
• Walsh L P, Webster D R, Stocco D M. Dimethoate inhibits steroidogenesis by disrupting transcription of the steroidogenic acute regulatory (StAR) gene. J Endocrinol 2000; 167: 253–63
   PubMed Web of Science ®Google Scholar
• Majdic G, Sharpe R M, O'Shaughnessy P J, Saunders P T. Expression of cytochrome P450 17alpha-hydroxylase/C17–20 lyase in the fetal rat testis is reduced by maternal exposure to exogenous estrogens. Endocrinology 1996; 137: 1063–70
   PubMed Web of Science ®Google Scholar
• Akingbemi B T, Ge R S, Klinefelter G R, Gunsalus G L, Hardy M P. A metabolite of methoxychlor, 2,2-bis(p-hydroxy-phenyl)-1,1,1-trichloroethane, reduces testosterone biosynthesis in rat Leydig cells through suppression of steady-state messenger ribonucleic acid levels of the cholesterol side-chain cleavage enzyme. Biol Reprod 2000; 62: 571–8
   PubMed Web of Science ®Google Scholar
• Jones T M, Fang V S, Landau R L, Rosenfield R. Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab 1978; 47: 1368–73
   PubMed Web of Science ®Google Scholar
• Patterson M N, Hughes I A, Gottlieb B, Pinsky L. The androgen receptor gene mutations database. Nucleic Acids Res 1994; 22: 3560–2
   PubMed Web of Science ®Google Scholar
• Orth J M, Gunsalus G L, Lamperti A A. Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology 1988; 122: 787–94
   PubMed Web of Science ®Google Scholar
• Steinberger A, Steinberger E. Replication pattern of Sertoli cells in maturing rat testis in vivo and in organ culture. Biol Reprod 1971; 4: 84–7
   PubMedGoogle Scholar
• Sinha Hikim A P, Rajavashisth T B, Siha Hikim I, Lue Y, Bonavera J J, Leung A, et al. Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation. Biol Reprod 1997; 57: 1193–201
   PubMed Web of Science ®Google Scholar
• Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth G A, Reissmann T, Meistrich M L. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology 2000; 14: 1735–45
   Google Scholar
• Cook J C, Johnson L, O'Connor J C, Biegel L B, Krams C H, Frame S R, et al. Effects of dietary 17 beta-estradiol exposure on serum hormone concentrations and testicular parameters in male Crl:CD BR rats. Toxicol Sci 1998; 44: 155–68
   PubMed Web of Science ®Google Scholar
• Gaytan F, Aguilar E. Quantitative analysis of Sertoli cells in neonatally oestrogen-treated rats. J Reprod Fertil 1987; 79: 589–98
   PubMedGoogle Scholar
• Sharpe R M, Atanassova N, McKinnell C, Parte P, Turner K J, Fisher J S, et al. Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: a possible role for estrogens in Sertoli cell development. Biol Reprod 1998; 59: 1084–94
   PubMed Web of Science ®Google Scholar
• Sjoberg P, Bondesson U, Gray T J, Ploen L. Effects of di(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in in vitro. Acta Pharmacol Toxicol (Copenh) 1986; 58: 225–33
   PubMedGoogle Scholar
• Dostal L A, Chapin R E, Stefanski S A, Harris M W, Schwetz B A. Testicular toxicity and reduced Sertoli cell numbers in neonatal rats by di(2-ethylhexyl)phthalate and the recovery of fertility as adults. Toxicol Appl Pharmacol 1988; 95: 104–21
   PubMed Web of Science ®Google Scholar
• Swan S H, Elkin E P, Fenster L. Have sperm densities declined? A reanalysis of global trend data. Environ Health Perspect 1997; 105: 1228–32
   PubMed Web of Science ®Google Scholar
• Faroon O, Kueberuwa S, Smith L, De Rosa C. ATSDR evaluation of health effects of chemicals. II. Mirex and chlordecone: health effects, toxicokinetics, human exposure, and environmental fate. Toxicol Ind Health 1995; 11: 1–203
   PubMed Web of Science ®Google Scholar
• Ekbom A, Akre O. Increasing incidence of testicular cancer - birth cohort effects. APMIS 1998; 106: 225–9, discussion 229–31
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebaek N E. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998; 106: 198–204
   PubMed Web of Science ®Google Scholar
• Russo J, Russo I H. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst 1978; 61: 1451–9
   PubMed Web of Science ®Google Scholar
• Liehr J G, Avitts T A, Randerath E, Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 1986; 83: 5301–5
   PubMed Web of Science ®Google Scholar
• Reuber M D. Carcinogenicity and toxicity of methoxychlor. Environ Health Perspect 1980; 36: 205–19
   PubMed Web of Science ®Google Scholar
• Atkinson A, Roy D. In vivo DNA adduct formation by bisphenol A. Environ Mol Mutagen 1995; 26: 60–6
   PubMed Web of Science ®Google Scholar
• Atkinson A, Roy D. In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). Biochem Biophys Res Commun 1995; 210: 424–33
   PubMed Web of Science ®Google Scholar
• Cook J C, Klinefelter G R, Hardisty J F, Sharpe R M, Foster P M. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol 1999; 29: 169–261
   PubMed Web of Science ®Google Scholar
• Jegou B, Sharpe R M. Paracrine mechanisms in testicular control. Molecular biology of the male reproductive system, D de Kretser. Academic Press, New York, NY 1993; 271–310
   Google Scholar
• He W W, Kumar M V, Tindall D J. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse. Nucleic Acids Res 1991; 19: 2373–8
   PubMed Web of Science ®Google Scholar
• Shupnik M A. Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone. Biol Reprod 1996; 54: 279–86
   PubMed Web of Science ®Google Scholar
• Gregg D W, Schwall R H, Nett T M. Regulation of gonadotropin secretion and number of gonadotropin-releasing hormone receptors by inhibin, activin-A, and estradiol. Biol Reprod 1991; 44: 725–32
   PubMed Web of Science ®Google Scholar
• Shull J D, Gorski J. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine. Mol Pharmacol 1990; 37: 215–21
   PubMed Web of Science ®Google Scholar
• Bagatell C J, Dahl K D, Bremner W J. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl 1994; 15: 15–21
   PubMedGoogle Scholar
• Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337: 91–5
   PubMed Web of Science ®Google Scholar
• vom Saal F, Timms B G. The role of natural and manmade estrogens in prostate development. Endocrine disruptors: effects on male and female reproductive systems, R K Naz. CRC, New York, NY 1999; 307–28
   Google Scholar
• Tangbanluekal L, Robinette C L. Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats. Endocrinology 1993; 132: 2407–16
   PubMed Web of Science ®Google Scholar
• Santti R, Newbold R R, Makela S, Pylkkanen L, McLachlan J A. Developmental estrogenization and prostatic neoplasia. Prostate 1994; 24: 67–78
   PubMed Web of Science ®Google Scholar
• Pogach L M, Vaitukaitis J L. Clinical usefulness of markers in monitoring patients with cancer. Adv Exp Med Biol 1981; 138: 387–403
   PubMed Web of Science ®Google Scholar
• Blake C A, Boockfor F R. Chronic administration of the environmental pollutant 4-tert-octylphenol to adult male rats interferes with the secretion of luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone. Biol Reprod 1997; 57: 255–66
   PubMed Web of Science ®Google Scholar
• Cooke P S, Eroschenko V P. Inhibitory effects of technical grade methoxychlor on development of neonatal male mouse reproductive organs. Biol Reprod 1990; 42: 585–96
   PubMed Web of Science ®Google Scholar
• Palanza P, Parmigiani S, Liu H, vom Saal F S. Prenatal exposure to low doses of the estrogenic chemicals diethyl-stilbestrol and o,p'-DDT alters aggressive behavior of male and female house mice. Pharmacol Biochem Behav 1999; 64: 665–72
   PubMed Web of Science ®Google Scholar
• Colon I, Caro D, Bourdony C J, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000; 108: 895–900
   PubMed Web of Science ®Google Scholar
• Blount B C, Silva M J, Caudill S P, Needham L L, Pickle J L, Sampson E J, et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 2000; 108: 972–82
   Web of Science ®Google Scholar
• Moline J M, Golden A L, Bar-Chama N, Smith E, Rauch M E, Chapin R E, et al. Exposure to hazardous substances and male reproductive health: a research framework. Environ Health Perspect 2000; 108: 803–13
   PubMed Web of Science ®Google Scholar
• Lamb J C, Chapin R E. Testicular and germ cell toxicity: in vitro approaches. Reprod Toxicol 1993; 7(Suppl 1)17–22
   PubMedGoogle Scholar
• Nagel S C, vom Saal F S, Welshons W V. Developmental effects of estrogenic chemicals are predicted by an in vitro assay incorporating modification of cell uptake by serum. J Steroid Biochem Mol Biol 1999; 69: 343–57
   PubMed Web of Science ®Google Scholar
• Howdeshell K L, Hotchkiss A K, Thayer K A, Vandenbergh J C, vom Saal F S. Exposure to bisphenol A advances puberty. Nature 1999; 401: 763–4
   PubMed Web of Science ®Google Scholar
• vom Saal F S, Timms B G, Montano M M, Palanza P, Thayer K A, Nagel S C, et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997; 94: 2056–61
   PubMed Web of Science ®Google Scholar
• Spearow J L, Doemeny P, Sera R, Leffler R, Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 1999; 285: 1259–61
   PubMed Web of Science ®Google Scholar
• Steinmetz R, Brown N G, Allen D L, Bigsby R M, Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 1997; 138: 1780–6
   PubMed Web of Science ®Google Scholar
• Helmuth L. Women's health. Reports see progress, problems, in trials. Science 2000; 288: 1562–3
   PubMed Web of Science ®Google Scholar
• Messina M, Barnes S, Setchell K D. Phyto-oestrogens and breast cancer. Lancet 1997; 350: 971–2
   PubMed Web of Science ®Google Scholar
• Messina M J, Persky V, Setchell K D, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113–31
   PubMed Web of Science ®Google Scholar
• Fotsis T, Pepper M S, Aktas E, Breit S, Rasku S, Adlercreutz H, et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916–21
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997; 29: 95–120
   PubMed Web of Science ®Google Scholar